These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19842236)

  • 1. Controversies about occult hepatitis B virus infection.
    Ozaslan E; Purnak T
    World J Gastroenterol; 2009 Oct; 15(39):4986-7. PubMed ID: 19842236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological techniques for the diagnosis and monitoring of hepatitis B and C.
    Chevaliez S; Pawlotsky JM
    Ann Hepatol; 2009; 8(1):7-12. PubMed ID: 19221527
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.
    Muto J; Sugiyama M; Shirabe K; Mukaide M; Kirikae-Muto I; Ikegami T; Yoshizumi T; Yamashita YI; Maehara Y; Mizokami M
    Ann Hepatol; 2018 July - August ,; 17(4):596-603. PubMed ID: 29893701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
    Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
    J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New viral biomarkers for Hepatitis B: Are we able to change practice?
    Höner Zu Siederdissen C; Maasoumy B; Cornberg M
    J Viral Hepat; 2018 Nov; 25(11):1226-1235. PubMed ID: 30187603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges to a Cure for HBV Infection.
    Testoni B; Levrero M; Zoulim F
    Semin Liver Dis; 2017 Aug; 37(3):231-242. PubMed ID: 28847034
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of lamivudine in the treatment of chronic hepatitis B virus infection.
    Hagmeyer KO; Pan YY
    Ann Pharmacother; 1999 Oct; 33(10):1104-12. PubMed ID: 10534223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource-limited settings by Loop-Mediated Isothermal Amplification assay.
    Akram A; Islam SMR; Munshi SU; Tabassum S
    J Viral Hepat; 2018 Nov; 25(11):1306-1311. PubMed ID: 29768691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis B infection in pregnancy illustrated by a case of successful treatment with entecavir.
    Kakogawa J; Sakurabashi A; Sadatsuki M; Gomibuchi H; Minoura S
    Arch Gynecol Obstet; 2011 Dec; 284(6):1595-6. PubMed ID: 21861151
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of the treatment of chronic hepatitis B on HBV DNA suppression and prevention of disease progression].
    Pawłowska M
    Przegl Epidemiol; 2008; 62(1):139-42. PubMed ID: 18536236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously.
    Cheng HR; Kao JH; Wu HL; Chen TC; Tseng TC; Liu CH; Su TH; Chen PJ; Chen DS; Liu CJ
    Liver Int; 2014 Jul; 34(6):e71-9. PubMed ID: 24119014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of occult hepatitis B infection in an African urban population.
    Apica BS; Seremba E; Rule J; Yuan HJ; Lee WM
    J Med Virol; 2016 Apr; 88(4):674-80. PubMed ID: 26334654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P; Margaritis AR; Seed CR; Yang H;
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.
    Amponsah-Dacosta E; Selabe SG; Mphahlele MJ
    J Med Virol; 2018 Feb; 90(2):291-303. PubMed ID: 28971485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
    Dusheiko G
    Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of chronic hepatitis B: an update.
    Negro F
    Swiss Med Wkly; 2011; 141():w13264. PubMed ID: 21913139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
    Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
    Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Booster immunity - diagnosis of chronic hepatitis B viral infection.
    Komitova RT; Kevorkyan AK; Atanasova MV; Ivanova AV; Golkocheva-Markova E
    J Infect Dev Ctries; 2019 Mar; 13(3):255-260. PubMed ID: 32040457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.
    Wei Q; Xu X; Ling Q; Zhou B; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):251-5. PubMed ID: 23742769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection.
    Tajik Z; Bokharaei-Salim F; Ghorbani S; Keyvani H; Esghaei M; Monavari SH; Ataei-Pirkooh A; Garshasbi S; Donyavi T; Fakhim A
    Arch Virol; 2018 Jun; 163(6):1559-1566. PubMed ID: 29476259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.